Doctors test personalized drug cocktails for Tough-to-Treat blood cancer
NCT ID NCT04925193
Summary
This study tests whether doctors can choose effective drug combinations for patients with multiple myeloma that has returned or stopped responding to previous treatments. Eighteen participants will receive one of three different drug combinations based on their doctor's judgment, while researchers also analyze how well lab tests could predict which drugs would work best. The goal is to see if this personalized approach can help control the cancer in most patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA IN RELAPSE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado Hospital
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.